Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank9
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P9
Near historical low
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-212.33%
202453.73%
2023-61.74%
202247.62%
2021-273.11%
2020167.82%
201913.06%
2018-13.69%
2017-164.38%
201612.38%